COVID-19 Impact on Global Nonsteroidal Antiinflammatory Drugs, Market Insights and Forecast to 2026
Nonsteroidal Antiinflammatory Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nonsteroidal Antiinflammatory Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Nonsteroidal Antiinflammatory Drugs market is segmented into
The Nonsteroidal Antiinflammatory Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nonsteroidal Antiinflammatory Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Nonsteroidal Antiinflammatory Drugs Market Share Analysis
Nonsteroidal Antiinflammatory Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nonsteroidal Antiinflammatory Drugs business, the date to enter into the Nonsteroidal Antiinflammatory Drugs market, Nonsteroidal Antiinflammatory Drugs product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Nonsteroidal Antiinflammatory Drugs market is segmented into
- Oral
- Injection
- Osteoarthritis
- Muscle Aches
- Backaches
- Dental Pain
- Others
The Nonsteroidal Antiinflammatory Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nonsteroidal Antiinflammatory Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Nonsteroidal Antiinflammatory Drugs Market Share Analysis
Nonsteroidal Antiinflammatory Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nonsteroidal Antiinflammatory Drugs business, the date to enter into the Nonsteroidal Antiinflammatory Drugs market, Nonsteroidal Antiinflammatory Drugs product introduction, recent developments, etc.
The major vendors covered:
- Sanofi S.A.
- Novartis AG
- GlaxoSmithKline PLC
- Pfizer
- DOMESCO
1 STUDY COVERAGE
1.1 Nonsteroidal Antiinflammatory Drugs Product Introduction
1.2 Market Segments
1.3 Key Nonsteroidal Antiinflammatory Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Nonsteroidal Antiinflammatory Drugs Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Nonsteroidal Antiinflammatory Drugs Market Size Growth Rate by Application
1.5.2 Osteoarthritis
1.5.3 Muscle Aches
1.5.4 Backaches
1.5.5 Dental Pain
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Nonsteroidal Antiinflammatory Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Nonsteroidal Antiinflammatory Drugs Industry
1.6.1.1 Nonsteroidal Antiinflammatory Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Nonsteroidal Antiinflammatory Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Nonsteroidal Antiinflammatory Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Nonsteroidal Antiinflammatory Drugs Market Size Estimates and Forecasts
2.1.1 Global Nonsteroidal Antiinflammatory Drugs Revenue 2015-2026
2.1.2 Global Nonsteroidal Antiinflammatory Drugs Sales 2015-2026
2.2 Nonsteroidal Antiinflammatory Drugs Market Size by Region: 2020 Versus 2026
2.2.1 Global Nonsteroidal Antiinflammatory Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Nonsteroidal Antiinflammatory Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL NONSTEROIDAL ANTIINFLAMMATORY DRUGS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Nonsteroidal Antiinflammatory Drugs Sales by Manufacturers
3.1.1 Nonsteroidal Antiinflammatory Drugs Sales by Manufacturers (2015-2020)
3.1.2 Nonsteroidal Antiinflammatory Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Nonsteroidal Antiinflammatory Drugs Revenue by Manufacturers
3.2.1 Nonsteroidal Antiinflammatory Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Nonsteroidal Antiinflammatory Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Nonsteroidal Antiinflammatory Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Nonsteroidal Antiinflammatory Drugs Revenue in 2019
3.2.5 Global Nonsteroidal Antiinflammatory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Nonsteroidal Antiinflammatory Drugs Price by Manufacturers
3.4 Nonsteroidal Antiinflammatory Drugs Manufacturing Base Distribution, Product Types
3.4.1 Nonsteroidal Antiinflammatory Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nonsteroidal Antiinflammatory Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Nonsteroidal Antiinflammatory Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Nonsteroidal Antiinflammatory Drugs Market Size by Type (2015-2020)
4.1.1 Global Nonsteroidal Antiinflammatory Drugs Sales by Type (2015-2020)
4.1.2 Global Nonsteroidal Antiinflammatory Drugs Revenue by Type (2015-2020)
4.1.3 Nonsteroidal Antiinflammatory Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Nonsteroidal Antiinflammatory Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Nonsteroidal Antiinflammatory Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Nonsteroidal Antiinflammatory Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Nonsteroidal Antiinflammatory Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Nonsteroidal Antiinflammatory Drugs Market Size by Application (2015-2020)
5.1.1 Global Nonsteroidal Antiinflammatory Drugs Sales by Application (2015-2020)
5.1.2 Global Nonsteroidal Antiinflammatory Drugs Revenue by Application (2015-2020)
5.1.3 Nonsteroidal Antiinflammatory Drugs Price by Application (2015-2020)
5.2 Nonsteroidal Antiinflammatory Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Nonsteroidal Antiinflammatory Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Nonsteroidal Antiinflammatory Drugs Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Nonsteroidal Antiinflammatory Drugs by Country
6.1.1 North America Nonsteroidal Antiinflammatory Drugs Sales by Country
6.1.2 North America Nonsteroidal Antiinflammatory Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Type
6.3 North America Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Application
7 EUROPE
7.1 Europe Nonsteroidal Antiinflammatory Drugs by Country
7.1.1 Europe Nonsteroidal Antiinflammatory Drugs Sales by Country
7.1.2 Europe Nonsteroidal Antiinflammatory Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Type
7.3 Europe Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Nonsteroidal Antiinflammatory Drugs by Region
8.1.1 Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales by Region
8.1.2 Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Type
8.3 Asia Pacific Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Nonsteroidal Antiinflammatory Drugs by Country
9.1.1 Latin America Nonsteroidal Antiinflammatory Drugs Sales by Country
9.1.2 Latin America Nonsteroidal Antiinflammatory Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Type
9.3 Central & South America Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Nonsteroidal Antiinflammatory Drugs by Country
10.1.1 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales by Country
10.1.2 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Sanofi S.A.
11.1.1 Sanofi S.A. Corporation Information
11.1.2 Sanofi S.A. Description, Business Overview and Total Revenue
11.1.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Products Offered
11.1.5 Sanofi S.A. Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Corporation Information
11.2.2 Novartis AG Description, Business Overview and Total Revenue
11.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis AG Nonsteroidal Antiinflammatory Drugs Products Offered
11.2.5 Novartis AG Recent Development
11.3 GlaxoSmithKline PLC
11.3.1 GlaxoSmithKline PLC Corporation Information
11.3.2 GlaxoSmithKline PLC Description, Business Overview and Total Revenue
11.3.3 GlaxoSmithKline PLC Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Products Offered
11.3.5 GlaxoSmithKline PLC Recent Development
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description, Business Overview and Total Revenue
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Nonsteroidal Antiinflammatory Drugs Products Offered
11.4.5 Pfizer Recent Development
11.5 DOMESCO
11.5.1 DOMESCO Corporation Information
11.5.2 DOMESCO Description, Business Overview and Total Revenue
11.5.3 DOMESCO Sales, Revenue and Gross Margin (2015-2020)
11.5.4 DOMESCO Nonsteroidal Antiinflammatory Drugs Products Offered
11.5.5 DOMESCO Recent Development
11.1 Sanofi S.A.
11.1.1 Sanofi S.A. Corporation Information
11.1.2 Sanofi S.A. Description, Business Overview and Total Revenue
11.1.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Products Offered
11.1.5 Sanofi S.A. Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Nonsteroidal Antiinflammatory Drugs Market Estimates and Projections by Region
12.1.1 Global Nonsteroidal Antiinflammatory Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Nonsteroidal Antiinflammatory Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Nonsteroidal Antiinflammatory Drugs Sales Forecast (2021-2026)
12.2.2 North America: Nonsteroidal Antiinflammatory Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Nonsteroidal Antiinflammatory Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Nonsteroidal Antiinflammatory Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Nonsteroidal Antiinflammatory Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Nonsteroidal Antiinflammatory Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Nonsteroidal Antiinflammatory Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Nonsteroidal Antiinflammatory Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Nonsteroidal Antiinflammatory Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Nonsteroidal Antiinflammatory Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Nonsteroidal Antiinflammatory Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Nonsteroidal Antiinflammatory Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Nonsteroidal Antiinflammatory Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Nonsteroidal Antiinflammatory Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Nonsteroidal Antiinflammatory Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Nonsteroidal Antiinflammatory Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Nonsteroidal Antiinflammatory Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Nonsteroidal Antiinflammatory Drugs Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Nonsteroidal Antiinflammatory Drugs Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Nonsteroidal Antiinflammatory Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Nonsteroidal Antiinflammatory Drugs Product Introduction
1.2 Market Segments
1.3 Key Nonsteroidal Antiinflammatory Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Nonsteroidal Antiinflammatory Drugs Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Nonsteroidal Antiinflammatory Drugs Market Size Growth Rate by Application
1.5.2 Osteoarthritis
1.5.3 Muscle Aches
1.5.4 Backaches
1.5.5 Dental Pain
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Nonsteroidal Antiinflammatory Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Nonsteroidal Antiinflammatory Drugs Industry
1.6.1.1 Nonsteroidal Antiinflammatory Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Nonsteroidal Antiinflammatory Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Nonsteroidal Antiinflammatory Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Nonsteroidal Antiinflammatory Drugs Market Size Estimates and Forecasts
2.1.1 Global Nonsteroidal Antiinflammatory Drugs Revenue 2015-2026
2.1.2 Global Nonsteroidal Antiinflammatory Drugs Sales 2015-2026
2.2 Nonsteroidal Antiinflammatory Drugs Market Size by Region: 2020 Versus 2026
2.2.1 Global Nonsteroidal Antiinflammatory Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Nonsteroidal Antiinflammatory Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL NONSTEROIDAL ANTIINFLAMMATORY DRUGS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Nonsteroidal Antiinflammatory Drugs Sales by Manufacturers
3.1.1 Nonsteroidal Antiinflammatory Drugs Sales by Manufacturers (2015-2020)
3.1.2 Nonsteroidal Antiinflammatory Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Nonsteroidal Antiinflammatory Drugs Revenue by Manufacturers
3.2.1 Nonsteroidal Antiinflammatory Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Nonsteroidal Antiinflammatory Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Nonsteroidal Antiinflammatory Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Nonsteroidal Antiinflammatory Drugs Revenue in 2019
3.2.5 Global Nonsteroidal Antiinflammatory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Nonsteroidal Antiinflammatory Drugs Price by Manufacturers
3.4 Nonsteroidal Antiinflammatory Drugs Manufacturing Base Distribution, Product Types
3.4.1 Nonsteroidal Antiinflammatory Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nonsteroidal Antiinflammatory Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Nonsteroidal Antiinflammatory Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Nonsteroidal Antiinflammatory Drugs Market Size by Type (2015-2020)
4.1.1 Global Nonsteroidal Antiinflammatory Drugs Sales by Type (2015-2020)
4.1.2 Global Nonsteroidal Antiinflammatory Drugs Revenue by Type (2015-2020)
4.1.3 Nonsteroidal Antiinflammatory Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Nonsteroidal Antiinflammatory Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Nonsteroidal Antiinflammatory Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Nonsteroidal Antiinflammatory Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Nonsteroidal Antiinflammatory Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Nonsteroidal Antiinflammatory Drugs Market Size by Application (2015-2020)
5.1.1 Global Nonsteroidal Antiinflammatory Drugs Sales by Application (2015-2020)
5.1.2 Global Nonsteroidal Antiinflammatory Drugs Revenue by Application (2015-2020)
5.1.3 Nonsteroidal Antiinflammatory Drugs Price by Application (2015-2020)
5.2 Nonsteroidal Antiinflammatory Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Nonsteroidal Antiinflammatory Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Nonsteroidal Antiinflammatory Drugs Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Nonsteroidal Antiinflammatory Drugs by Country
6.1.1 North America Nonsteroidal Antiinflammatory Drugs Sales by Country
6.1.2 North America Nonsteroidal Antiinflammatory Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Type
6.3 North America Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Application
7 EUROPE
7.1 Europe Nonsteroidal Antiinflammatory Drugs by Country
7.1.1 Europe Nonsteroidal Antiinflammatory Drugs Sales by Country
7.1.2 Europe Nonsteroidal Antiinflammatory Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Type
7.3 Europe Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Nonsteroidal Antiinflammatory Drugs by Region
8.1.1 Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales by Region
8.1.2 Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Type
8.3 Asia Pacific Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Nonsteroidal Antiinflammatory Drugs by Country
9.1.1 Latin America Nonsteroidal Antiinflammatory Drugs Sales by Country
9.1.2 Latin America Nonsteroidal Antiinflammatory Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Type
9.3 Central & South America Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Nonsteroidal Antiinflammatory Drugs by Country
10.1.1 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales by Country
10.1.2 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Sanofi S.A.
11.1.1 Sanofi S.A. Corporation Information
11.1.2 Sanofi S.A. Description, Business Overview and Total Revenue
11.1.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Products Offered
11.1.5 Sanofi S.A. Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Corporation Information
11.2.2 Novartis AG Description, Business Overview and Total Revenue
11.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis AG Nonsteroidal Antiinflammatory Drugs Products Offered
11.2.5 Novartis AG Recent Development
11.3 GlaxoSmithKline PLC
11.3.1 GlaxoSmithKline PLC Corporation Information
11.3.2 GlaxoSmithKline PLC Description, Business Overview and Total Revenue
11.3.3 GlaxoSmithKline PLC Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Products Offered
11.3.5 GlaxoSmithKline PLC Recent Development
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description, Business Overview and Total Revenue
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Nonsteroidal Antiinflammatory Drugs Products Offered
11.4.5 Pfizer Recent Development
11.5 DOMESCO
11.5.1 DOMESCO Corporation Information
11.5.2 DOMESCO Description, Business Overview and Total Revenue
11.5.3 DOMESCO Sales, Revenue and Gross Margin (2015-2020)
11.5.4 DOMESCO Nonsteroidal Antiinflammatory Drugs Products Offered
11.5.5 DOMESCO Recent Development
11.1 Sanofi S.A.
11.1.1 Sanofi S.A. Corporation Information
11.1.2 Sanofi S.A. Description, Business Overview and Total Revenue
11.1.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Products Offered
11.1.5 Sanofi S.A. Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Nonsteroidal Antiinflammatory Drugs Market Estimates and Projections by Region
12.1.1 Global Nonsteroidal Antiinflammatory Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Nonsteroidal Antiinflammatory Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Nonsteroidal Antiinflammatory Drugs Sales Forecast (2021-2026)
12.2.2 North America: Nonsteroidal Antiinflammatory Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Nonsteroidal Antiinflammatory Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Nonsteroidal Antiinflammatory Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Nonsteroidal Antiinflammatory Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Nonsteroidal Antiinflammatory Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Nonsteroidal Antiinflammatory Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Nonsteroidal Antiinflammatory Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Nonsteroidal Antiinflammatory Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Nonsteroidal Antiinflammatory Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Nonsteroidal Antiinflammatory Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Nonsteroidal Antiinflammatory Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Nonsteroidal Antiinflammatory Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Nonsteroidal Antiinflammatory Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Nonsteroidal Antiinflammatory Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Nonsteroidal Antiinflammatory Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Nonsteroidal Antiinflammatory Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Nonsteroidal Antiinflammatory Drugs Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Nonsteroidal Antiinflammatory Drugs Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Nonsteroidal Antiinflammatory Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Nonsteroidal Antiinflammatory Drugs Market Segments
Table 2. Ranking of Global Top Nonsteroidal Antiinflammatory Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Nonsteroidal Antiinflammatory Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Injection
Table 6. COVID-19 Impact Global Market: (Four Nonsteroidal Antiinflammatory Drugs Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Nonsteroidal Antiinflammatory Drugs Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Nonsteroidal Antiinflammatory Drugs Players to Combat Covid-19 Impact
Table 11. Global Nonsteroidal Antiinflammatory Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Nonsteroidal Antiinflammatory Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Nonsteroidal Antiinflammatory Drugs Sales by Regions 2015-2020 (K MT)
Table 14. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Regions (2015-2020)
Table 15. Global Nonsteroidal Antiinflammatory Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Nonsteroidal Antiinflammatory Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Nonsteroidal Antiinflammatory Drugs Sales Share by Manufacturers (2015-2020)
Table 18. Global Nonsteroidal Antiinflammatory Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Nonsteroidal Antiinflammatory Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nonsteroidal Antiinflammatory Drugs as of 2019)
Table 20. Nonsteroidal Antiinflammatory Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Nonsteroidal Antiinflammatory Drugs Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Nonsteroidal Antiinflammatory Drugs Price (2015-2020) (USD/MT)
Table 23. Nonsteroidal Antiinflammatory Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Nonsteroidal Antiinflammatory Drugs Product Type
Table 25. Date of International Manufacturers Enter into Nonsteroidal Antiinflammatory Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Nonsteroidal Antiinflammatory Drugs Sales by Type (2015-2020) (K MT)
Table 28. Global Nonsteroidal Antiinflammatory Drugs Sales Share by Type (2015-2020)
Table 29. Global Nonsteroidal Antiinflammatory Drugs Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Nonsteroidal Antiinflammatory Drugs Revenue Share by Type (2015-2020)
Table 31. Nonsteroidal Antiinflammatory Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Nonsteroidal Antiinflammatory Drugs Sales by Application (2015-2020) (K MT)
Table 33. Global Nonsteroidal Antiinflammatory Drugs Sales Share by Application (2015-2020)
Table 34. North America Nonsteroidal Antiinflammatory Drugs Sales by Country (2015-2020) (K MT)
Table 35. North America Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country (2015-2020)
Table 36. North America Nonsteroidal Antiinflammatory Drugs Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country (2015-2020)
Table 38. North America Nonsteroidal Antiinflammatory Drugs Sales by Type (2015-2020) (K MT)
Table 39. North America Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
Table 40. North America Nonsteroidal Antiinflammatory Drugs Sales by Application (2015-2020) (K MT)
Table 41. North America Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
Table 42. Europe Nonsteroidal Antiinflammatory Drugs Sales by Country (2015-2020) (K MT)
Table 43. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country (2015-2020)
Table 44. Europe Nonsteroidal Antiinflammatory Drugs Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country (2015-2020)
Table 46. Europe Nonsteroidal Antiinflammatory Drugs Sales by Type (2015-2020) (K MT)
Table 47. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
Table 48. Europe Nonsteroidal Antiinflammatory Drugs Sales by Application (2015-2020) (K MT)
Table 49. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
Table 58. Latin America Nonsteroidal Antiinflammatory Drugs Sales by Country (2015-2020) (K MT)
Table 59. Latin America Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Nonsteroidal Antiinflammatory Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country (2015-2020)
Table 62. Latin America Nonsteroidal Antiinflammatory Drugs Sales by Type (2015-2020) (K MT)
Table 63. Latin America Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
Table 64. Latin America Nonsteroidal Antiinflammatory Drugs Sales by Application (2015-2020) (K MT)
Table 65. Latin America Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
Table 74. Sanofi S.A. Corporation Information
Table 75. Sanofi S.A. Description and Major Businesses
Table 76. Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Sanofi S.A. Product
Table 78. Sanofi S.A. Recent Development
Table 79. Novartis AG Corporation Information
Table 80. Novartis AG Description and Major Businesses
Table 81. Novartis AG Nonsteroidal Antiinflammatory Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Novartis AG Product
Table 83. Novartis AG Recent Development
Table 84. GlaxoSmithKline PLC Corporation Information
Table 85. GlaxoSmithKline PLC Description and Major Businesses
Table 86. GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. GlaxoSmithKline PLC Product
Table 88. GlaxoSmithKline PLC Recent Development
Table 89. Pfizer Corporation Information
Table 90. Pfizer Description and Major Businesses
Table 91. Pfizer Nonsteroidal Antiinflammatory Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Pfizer Product
Table 93. Pfizer Recent Development
Table 94. DOMESCO Corporation Information
Table 95. DOMESCO Description and Major Businesses
Table 96. DOMESCO Nonsteroidal Antiinflammatory Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. DOMESCO Product
Table 98. DOMESCO Recent Development
Table 99. Global Nonsteroidal Antiinflammatory Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 100. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 101. Global Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 102. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 103. North America: Nonsteroidal Antiinflammatory Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 104. North America: Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Europe: Nonsteroidal Antiinflammatory Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 106. Europe: Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Asia Pacific: Nonsteroidal Antiinflammatory Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 108. Asia Pacific: Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Latin America: Nonsteroidal Antiinflammatory Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 110. Latin America: Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Middle East and Africa: Nonsteroidal Antiinflammatory Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 112. Middle East and Africa: Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Market Risks
Table 116. Main Points Interviewed from Key Nonsteroidal Antiinflammatory Drugs Players
Table 117. Nonsteroidal Antiinflammatory Drugs Customers List
Table 118. Nonsteroidal Antiinflammatory Drugs Distributors List
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 1. Nonsteroidal Antiinflammatory Drugs Market Segments
Table 2. Ranking of Global Top Nonsteroidal Antiinflammatory Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Nonsteroidal Antiinflammatory Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Injection
Table 6. COVID-19 Impact Global Market: (Four Nonsteroidal Antiinflammatory Drugs Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Nonsteroidal Antiinflammatory Drugs Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Nonsteroidal Antiinflammatory Drugs Players to Combat Covid-19 Impact
Table 11. Global Nonsteroidal Antiinflammatory Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Nonsteroidal Antiinflammatory Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Nonsteroidal Antiinflammatory Drugs Sales by Regions 2015-2020 (K MT)
Table 14. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Regions (2015-2020)
Table 15. Global Nonsteroidal Antiinflammatory Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Nonsteroidal Antiinflammatory Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Nonsteroidal Antiinflammatory Drugs Sales Share by Manufacturers (2015-2020)
Table 18. Global Nonsteroidal Antiinflammatory Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Nonsteroidal Antiinflammatory Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nonsteroidal Antiinflammatory Drugs as of 2019)
Table 20. Nonsteroidal Antiinflammatory Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Nonsteroidal Antiinflammatory Drugs Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Nonsteroidal Antiinflammatory Drugs Price (2015-2020) (USD/MT)
Table 23. Nonsteroidal Antiinflammatory Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Nonsteroidal Antiinflammatory Drugs Product Type
Table 25. Date of International Manufacturers Enter into Nonsteroidal Antiinflammatory Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Nonsteroidal Antiinflammatory Drugs Sales by Type (2015-2020) (K MT)
Table 28. Global Nonsteroidal Antiinflammatory Drugs Sales Share by Type (2015-2020)
Table 29. Global Nonsteroidal Antiinflammatory Drugs Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Nonsteroidal Antiinflammatory Drugs Revenue Share by Type (2015-2020)
Table 31. Nonsteroidal Antiinflammatory Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Nonsteroidal Antiinflammatory Drugs Sales by Application (2015-2020) (K MT)
Table 33. Global Nonsteroidal Antiinflammatory Drugs Sales Share by Application (2015-2020)
Table 34. North America Nonsteroidal Antiinflammatory Drugs Sales by Country (2015-2020) (K MT)
Table 35. North America Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country (2015-2020)
Table 36. North America Nonsteroidal Antiinflammatory Drugs Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country (2015-2020)
Table 38. North America Nonsteroidal Antiinflammatory Drugs Sales by Type (2015-2020) (K MT)
Table 39. North America Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
Table 40. North America Nonsteroidal Antiinflammatory Drugs Sales by Application (2015-2020) (K MT)
Table 41. North America Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
Table 42. Europe Nonsteroidal Antiinflammatory Drugs Sales by Country (2015-2020) (K MT)
Table 43. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country (2015-2020)
Table 44. Europe Nonsteroidal Antiinflammatory Drugs Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country (2015-2020)
Table 46. Europe Nonsteroidal Antiinflammatory Drugs Sales by Type (2015-2020) (K MT)
Table 47. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
Table 48. Europe Nonsteroidal Antiinflammatory Drugs Sales by Application (2015-2020) (K MT)
Table 49. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
Table 58. Latin America Nonsteroidal Antiinflammatory Drugs Sales by Country (2015-2020) (K MT)
Table 59. Latin America Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Nonsteroidal Antiinflammatory Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country (2015-2020)
Table 62. Latin America Nonsteroidal Antiinflammatory Drugs Sales by Type (2015-2020) (K MT)
Table 63. Latin America Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
Table 64. Latin America Nonsteroidal Antiinflammatory Drugs Sales by Application (2015-2020) (K MT)
Table 65. Latin America Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
Table 74. Sanofi S.A. Corporation Information
Table 75. Sanofi S.A. Description and Major Businesses
Table 76. Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Sanofi S.A. Product
Table 78. Sanofi S.A. Recent Development
Table 79. Novartis AG Corporation Information
Table 80. Novartis AG Description and Major Businesses
Table 81. Novartis AG Nonsteroidal Antiinflammatory Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Novartis AG Product
Table 83. Novartis AG Recent Development
Table 84. GlaxoSmithKline PLC Corporation Information
Table 85. GlaxoSmithKline PLC Description and Major Businesses
Table 86. GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. GlaxoSmithKline PLC Product
Table 88. GlaxoSmithKline PLC Recent Development
Table 89. Pfizer Corporation Information
Table 90. Pfizer Description and Major Businesses
Table 91. Pfizer Nonsteroidal Antiinflammatory Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Pfizer Product
Table 93. Pfizer Recent Development
Table 94. DOMESCO Corporation Information
Table 95. DOMESCO Description and Major Businesses
Table 96. DOMESCO Nonsteroidal Antiinflammatory Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. DOMESCO Product
Table 98. DOMESCO Recent Development
Table 99. Global Nonsteroidal Antiinflammatory Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 100. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 101. Global Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 102. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 103. North America: Nonsteroidal Antiinflammatory Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 104. North America: Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Europe: Nonsteroidal Antiinflammatory Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 106. Europe: Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Asia Pacific: Nonsteroidal Antiinflammatory Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 108. Asia Pacific: Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Latin America: Nonsteroidal Antiinflammatory Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 110. Latin America: Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Middle East and Africa: Nonsteroidal Antiinflammatory Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 112. Middle East and Africa: Nonsteroidal Antiinflammatory Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Market Risks
Table 116. Main Points Interviewed from Key Nonsteroidal Antiinflammatory Drugs Players
Table 117. Nonsteroidal Antiinflammatory Drugs Customers List
Table 118. Nonsteroidal Antiinflammatory Drugs Distributors List
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Nonsteroidal Antiinflammatory Drugs Product Picture
Figure 2. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Osteoarthritis
Figure 7. Muscle Aches
Figure 8. Backaches
Figure 9. Dental Pain
Figure 10. Others
Figure 11. Nonsteroidal Antiinflammatory Drugs Report Years Considered
Figure 12. Global Nonsteroidal Antiinflammatory Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Nonsteroidal Antiinflammatory Drugs Sales 2015-2026 (K MT)
Figure 14. Global Nonsteroidal Antiinflammatory Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Region in 2019
Figure 17. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Region in 2019
Figure 19. Global Nonsteroidal Antiinflammatory Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Nonsteroidal Antiinflammatory Drugs Revenue in 2019
Figure 21. Nonsteroidal Antiinflammatory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type in 2019
Figure 24. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Type in 2019
Figure 26. Global Nonsteroidal Antiinflammatory Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application in 2019
Figure 29. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Application in 2019
Figure 31. North America Nonsteroidal Antiinflammatory Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country in 2019
Figure 34. North America Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Nonsteroidal Antiinflammatory Drugs Market Share by Type in 2019
Figure 40. North America Nonsteroidal Antiinflammatory Drugs Market Share by Application in 2019
Figure 41. Europe Nonsteroidal Antiinflammatory Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country in 2019
Figure 44. Europe Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country in 2019
Figure 45. Germany Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Nonsteroidal Antiinflammatory Drugs Market Share by Type in 2019
Figure 56. Europe Nonsteroidal Antiinflammatory Drugs Market Share by Application in 2019
Figure 57. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Region in 2019
Figure 61. China Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Nonsteroidal Antiinflammatory Drugs Market Share by Type in 2019
Figure 84. Asia Pacific Nonsteroidal Antiinflammatory Drugs Market Share by Application in 2019
Figure 85. Latin America Nonsteroidal Antiinflammatory Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Nonsteroidal Antiinflammatory Drugs Market Share by Type in 2019
Figure 96. Latin America Nonsteroidal Antiinflammatory Drugs Market Share by Application in 2019
Figure 97. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Market Share by Type in 2019
Figure 108. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Market Share by Application in 2019
Figure 109. Sanofi S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. GlaxoSmithKline PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. DOMESCO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. North America Nonsteroidal Antiinflammatory Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. North America Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Nonsteroidal Antiinflammatory Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Europe Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Nonsteroidal Antiinflammatory Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Latin America Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
Figure 1. Nonsteroidal Antiinflammatory Drugs Product Picture
Figure 2. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Osteoarthritis
Figure 7. Muscle Aches
Figure 8. Backaches
Figure 9. Dental Pain
Figure 10. Others
Figure 11. Nonsteroidal Antiinflammatory Drugs Report Years Considered
Figure 12. Global Nonsteroidal Antiinflammatory Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Nonsteroidal Antiinflammatory Drugs Sales 2015-2026 (K MT)
Figure 14. Global Nonsteroidal Antiinflammatory Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Region in 2019
Figure 17. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Region in 2019
Figure 19. Global Nonsteroidal Antiinflammatory Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Nonsteroidal Antiinflammatory Drugs Revenue in 2019
Figure 21. Nonsteroidal Antiinflammatory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type in 2019
Figure 24. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Type in 2019
Figure 26. Global Nonsteroidal Antiinflammatory Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application in 2019
Figure 29. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Application in 2019
Figure 31. North America Nonsteroidal Antiinflammatory Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country in 2019
Figure 34. North America Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Nonsteroidal Antiinflammatory Drugs Market Share by Type in 2019
Figure 40. North America Nonsteroidal Antiinflammatory Drugs Market Share by Application in 2019
Figure 41. Europe Nonsteroidal Antiinflammatory Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country in 2019
Figure 44. Europe Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country in 2019
Figure 45. Germany Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Nonsteroidal Antiinflammatory Drugs Market Share by Type in 2019
Figure 56. Europe Nonsteroidal Antiinflammatory Drugs Market Share by Application in 2019
Figure 57. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Region in 2019
Figure 61. China Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Nonsteroidal Antiinflammatory Drugs Market Share by Type in 2019
Figure 84. Asia Pacific Nonsteroidal Antiinflammatory Drugs Market Share by Application in 2019
Figure 85. Latin America Nonsteroidal Antiinflammatory Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Nonsteroidal Antiinflammatory Drugs Market Share by Type in 2019
Figure 96. Latin America Nonsteroidal Antiinflammatory Drugs Market Share by Application in 2019
Figure 97. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Nonsteroidal Antiinflammatory Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Market Share by Type in 2019
Figure 108. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Market Share by Application in 2019
Figure 109. Sanofi S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. GlaxoSmithKline PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. DOMESCO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. North America Nonsteroidal Antiinflammatory Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. North America Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Nonsteroidal Antiinflammatory Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Europe Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Nonsteroidal Antiinflammatory Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Latin America Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
